Cite
HARVARD Citation
Matic, N. et al. (n.d.). Clinical Impact of Rapid Identification (ID) and Phenotypic Antimicrobial Susceptibility Testing (AST) by Accelerate Pheno™ System (AXDX) for Gram-negative (GNB) Bloodstream Infections. Open forum infectious diseases. p. S595. [Online].